Selzentry and Edurant drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Selzentry (maraviroc) and Edurant (rilpivirine hydrochloride). Common drug interactions include chronic kidney disease among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Selzentry and Edurant. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Selzentry?

Selzentry has active ingredients of maraviroc. It is often used in hiv infection. eHealthMe is studying from 710 Selzentry users. Check the latest studies of Selzentry.

What is Edurant?

Edurant has active ingredients of rilpivirine hydrochloride. eHealthMe is studying from 2,238 Edurant users. Check the latest studies of Edurant.



On Jul, 05, 2026

17 people who take Selzentry and Edurant together, and have interactions are studied.

Selzentry and Edurant drug interactions.

What are the common drug interactions of Selzentry and Edurant, by gender? *:

female:

  1. Chronic kidney disease
  2. Fractured sacrum
  3. Hip fracture
  4. Wrist fracture
  5. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  6. Anxiety
  7. Bedridden
  8. Bone density decreased
  9. Decreased activity
  10. Depression

male:

  1. Chronic kidney disease
  2. Emotional distress
  3. Renal disorder (kidney disease)
  4. Renal failure (kidney dysfunction)
  5. Exercise tolerance decreased
  6. Foot fracture
  7. Insomnia (sleeplessness)
  8. Lumbar vertebral fracture
  9. Mobility decreased (ability to move is reduced)
  10. Myelitis (infection or the inflammation of white matter or gray matter of spinal cord which is a part of central nervous system)

What are the common drug interactions of Selzentry and Edurant, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chronic kidney disease
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Anxiety
  4. Bone density decreased
  5. Emotional distress
  6. Fractured sacrum
  7. Hip fracture
  8. Osteopenia (a condition where bone mineral density is lower than normal)
  9. Pain
  10. Wrist fracture

50-59:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Blood creatinine increased
  4. Exercise tolerance decreased
  5. Foot fracture
  6. Lumbar vertebral fracture
  7. Mobility decreased (ability to move is reduced)
  8. Myelitis (infection or the inflammation of white matter or gray matter of spinal cord which is a part of central nervous system)
  9. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  10. Osteopenia (a condition where bone mineral density is lower than normal)

60+:

  1. Drug ineffective
  2. Drug resistance (reduction in effectiveness of a drug)
  3. Pneumonia
  4. Viral load increased

What are the existing conditions these people have? *

  1. Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 3 people, 17.65%
  2. Lipodystrophy Acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired): 2 people, 11.76%
  3. Diabetes: 2 people, 11.76%
  4. Vitamin D Decreased: 1 person, 5.88%
  5. Muscle Spasms (muscle contraction): 1 person, 5.88%
  6. Indigestion: 1 person, 5.88%
  7. High Blood Pressure: 1 person, 5.88%
  8. High Blood Cholesterol: 1 person, 5.88%
  9. Herpes Virus Infection: 1 person, 5.88%
  10. Fatigue (feeling of tiredness): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Selzentry and Edurant?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Selzentry and Edurant:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Selzentry:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Edurant:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Selzentry and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Edurant and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on maraviroc and rilpivirine hydrochloride (the active ingredients of Selzentry and Edurant, respectively), and Selzentry and Edurant (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: